[Considerations on hyperkinesis caused by L-dopa: significance of the biochemical deficit and anatomical deficit].
D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced*; D009069:Movement Disorders / Q000188:drug therapy*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine
Considerazioni sulle ipercinesie da L-dopa: significato del deficit biochimico e del deficit anatomico.